| Steven M Cartun, MD | |
|
1808 Colonial Village Ln, Suite 103, Lancaster, PA 17601-6745 | |
| (717) 391-0172 | |
| (717) 391-7771 |
| Full Name | Steven M Cartun |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 1808 Colonial Village Ln, Lancaster, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053317602 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | MD043005L (Pennsylvania) | Primary |
| Entity Name | Philhaven |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043316441 PECOS PAC ID: 8729991419 Enrollment ID: O20031110000103 |
News Archive
Today's news regarding this health law provision comes from developments in Florida, Tennessee, Pennsylvania and Texas.
A remotely-controlled catheter device guided by magnetic fields provides a safe and practical method for delivering radio frequency ablation treatment in the hearts of patients with atrial fibrillation, according to a new study in the April 4, 2006, issue of the Journal of the American College of Cardiology.
As technology advances in the things we use every day, it's generally accepted they also become safer. But according to one UBC engineer, that may not be true for a large portion of the population.
Today, the U.S. Food and Drug Administration granted marketing authorization of the BioFire Respiratory Panel 2.1 (RP2.1), a diagnostic test for the simultaneous qualitative detection and identification of multiple respiratory viral and bacterial nucleic acids in nasopharyngeal swabs (NPS) obtained from individuals suspected of COVID-19 and other respiratory tract infections.
InForm, a AU$2.7 million EU-funded project involving world-leading research institutionsincluding the University of Sydney,hosted its first conference, 'NanoFormulation2010', in June at Stockholm University.
› Verified 2 days ago
| Entity Name | St Lukes Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700984622 PECOS PAC ID: 6709798333 Enrollment ID: O20040226000062 |
News Archive
Today's news regarding this health law provision comes from developments in Florida, Tennessee, Pennsylvania and Texas.
A remotely-controlled catheter device guided by magnetic fields provides a safe and practical method for delivering radio frequency ablation treatment in the hearts of patients with atrial fibrillation, according to a new study in the April 4, 2006, issue of the Journal of the American College of Cardiology.
As technology advances in the things we use every day, it's generally accepted they also become safer. But according to one UBC engineer, that may not be true for a large portion of the population.
Today, the U.S. Food and Drug Administration granted marketing authorization of the BioFire Respiratory Panel 2.1 (RP2.1), a diagnostic test for the simultaneous qualitative detection and identification of multiple respiratory viral and bacterial nucleic acids in nasopharyngeal swabs (NPS) obtained from individuals suspected of COVID-19 and other respiratory tract infections.
InForm, a AU$2.7 million EU-funded project involving world-leading research institutionsincluding the University of Sydney,hosted its first conference, 'NanoFormulation2010', in June at Stockholm University.
› Verified 2 days ago
| Entity Name | Momentum Services, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831250364 PECOS PAC ID: 2961502547 Enrollment ID: O20070711000795 |
News Archive
Today's news regarding this health law provision comes from developments in Florida, Tennessee, Pennsylvania and Texas.
A remotely-controlled catheter device guided by magnetic fields provides a safe and practical method for delivering radio frequency ablation treatment in the hearts of patients with atrial fibrillation, according to a new study in the April 4, 2006, issue of the Journal of the American College of Cardiology.
As technology advances in the things we use every day, it's generally accepted they also become safer. But according to one UBC engineer, that may not be true for a large portion of the population.
Today, the U.S. Food and Drug Administration granted marketing authorization of the BioFire Respiratory Panel 2.1 (RP2.1), a diagnostic test for the simultaneous qualitative detection and identification of multiple respiratory viral and bacterial nucleic acids in nasopharyngeal swabs (NPS) obtained from individuals suspected of COVID-19 and other respiratory tract infections.
InForm, a AU$2.7 million EU-funded project involving world-leading research institutionsincluding the University of Sydney,hosted its first conference, 'NanoFormulation2010', in June at Stockholm University.
› Verified 2 days ago
| Entity Name | Teamcare Behavioral Health, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043408818 PECOS PAC ID: 4183888324 Enrollment ID: O20120619000458 |
News Archive
Today's news regarding this health law provision comes from developments in Florida, Tennessee, Pennsylvania and Texas.
A remotely-controlled catheter device guided by magnetic fields provides a safe and practical method for delivering radio frequency ablation treatment in the hearts of patients with atrial fibrillation, according to a new study in the April 4, 2006, issue of the Journal of the American College of Cardiology.
As technology advances in the things we use every day, it's generally accepted they also become safer. But according to one UBC engineer, that may not be true for a large portion of the population.
Today, the U.S. Food and Drug Administration granted marketing authorization of the BioFire Respiratory Panel 2.1 (RP2.1), a diagnostic test for the simultaneous qualitative detection and identification of multiple respiratory viral and bacterial nucleic acids in nasopharyngeal swabs (NPS) obtained from individuals suspected of COVID-19 and other respiratory tract infections.
InForm, a AU$2.7 million EU-funded project involving world-leading research institutionsincluding the University of Sydney,hosted its first conference, 'NanoFormulation2010', in June at Stockholm University.
› Verified 2 days ago
| Entity Name | Vital Healthcare Solutions |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659736957 PECOS PAC ID: 3274830336 Enrollment ID: O20160405000879 |
News Archive
Today's news regarding this health law provision comes from developments in Florida, Tennessee, Pennsylvania and Texas.
A remotely-controlled catheter device guided by magnetic fields provides a safe and practical method for delivering radio frequency ablation treatment in the hearts of patients with atrial fibrillation, according to a new study in the April 4, 2006, issue of the Journal of the American College of Cardiology.
As technology advances in the things we use every day, it's generally accepted they also become safer. But according to one UBC engineer, that may not be true for a large portion of the population.
Today, the U.S. Food and Drug Administration granted marketing authorization of the BioFire Respiratory Panel 2.1 (RP2.1), a diagnostic test for the simultaneous qualitative detection and identification of multiple respiratory viral and bacterial nucleic acids in nasopharyngeal swabs (NPS) obtained from individuals suspected of COVID-19 and other respiratory tract infections.
InForm, a AU$2.7 million EU-funded project involving world-leading research institutionsincluding the University of Sydney,hosted its first conference, 'NanoFormulation2010', in June at Stockholm University.
› Verified 2 days ago
| Entity Name | Lancaster Behavioral Health Hospital Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063929115 PECOS PAC ID: 9234492059 Enrollment ID: O20180725003500 |
News Archive
Today's news regarding this health law provision comes from developments in Florida, Tennessee, Pennsylvania and Texas.
A remotely-controlled catheter device guided by magnetic fields provides a safe and practical method for delivering radio frequency ablation treatment in the hearts of patients with atrial fibrillation, according to a new study in the April 4, 2006, issue of the Journal of the American College of Cardiology.
As technology advances in the things we use every day, it's generally accepted they also become safer. But according to one UBC engineer, that may not be true for a large portion of the population.
Today, the U.S. Food and Drug Administration granted marketing authorization of the BioFire Respiratory Panel 2.1 (RP2.1), a diagnostic test for the simultaneous qualitative detection and identification of multiple respiratory viral and bacterial nucleic acids in nasopharyngeal swabs (NPS) obtained from individuals suspected of COVID-19 and other respiratory tract infections.
InForm, a AU$2.7 million EU-funded project involving world-leading research institutionsincluding the University of Sydney,hosted its first conference, 'NanoFormulation2010', in June at Stockholm University.
› Verified 2 days ago
| Entity Name | Spotlyte Behavioral Health Of Pennsylvania Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629696364 PECOS PAC ID: 1951728203 Enrollment ID: O20200901001229 |
News Archive
Today's news regarding this health law provision comes from developments in Florida, Tennessee, Pennsylvania and Texas.
A remotely-controlled catheter device guided by magnetic fields provides a safe and practical method for delivering radio frequency ablation treatment in the hearts of patients with atrial fibrillation, according to a new study in the April 4, 2006, issue of the Journal of the American College of Cardiology.
As technology advances in the things we use every day, it's generally accepted they also become safer. But according to one UBC engineer, that may not be true for a large portion of the population.
Today, the U.S. Food and Drug Administration granted marketing authorization of the BioFire Respiratory Panel 2.1 (RP2.1), a diagnostic test for the simultaneous qualitative detection and identification of multiple respiratory viral and bacterial nucleic acids in nasopharyngeal swabs (NPS) obtained from individuals suspected of COVID-19 and other respiratory tract infections.
InForm, a AU$2.7 million EU-funded project involving world-leading research institutionsincluding the University of Sydney,hosted its first conference, 'NanoFormulation2010', in June at Stockholm University.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Steven M Cartun, MD 1808 Colonial Village Ln, Suite 103, Lancaster, PA 17601-6745 Ph: (717) 391-0172 | Steven M Cartun, MD 1808 Colonial Village Ln, Suite 103, Lancaster, PA 17601-6745 Ph: (717) 391-0172 |
News Archive
Today's news regarding this health law provision comes from developments in Florida, Tennessee, Pennsylvania and Texas.
A remotely-controlled catheter device guided by magnetic fields provides a safe and practical method for delivering radio frequency ablation treatment in the hearts of patients with atrial fibrillation, according to a new study in the April 4, 2006, issue of the Journal of the American College of Cardiology.
As technology advances in the things we use every day, it's generally accepted they also become safer. But according to one UBC engineer, that may not be true for a large portion of the population.
Today, the U.S. Food and Drug Administration granted marketing authorization of the BioFire Respiratory Panel 2.1 (RP2.1), a diagnostic test for the simultaneous qualitative detection and identification of multiple respiratory viral and bacterial nucleic acids in nasopharyngeal swabs (NPS) obtained from individuals suspected of COVID-19 and other respiratory tract infections.
InForm, a AU$2.7 million EU-funded project involving world-leading research institutionsincluding the University of Sydney,hosted its first conference, 'NanoFormulation2010', in June at Stockholm University.
› Verified 2 days ago
David Petkash, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 555 N Duke St, Lancaster, PA 17602 Phone: 717-544-5511 | |
David N. Mccollum, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 555 North Duke Street, Neuroscience Service Line Administration, Lancaster, PA 17601 Phone: 717-544-5008 Fax: 717-544-5041 | |
Matthew Abraham Biever, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1808 Colonial Village Ln, Suite 103, Lancaster, PA 17601 Phone: 717-391-0172 Fax: 717-391-7771 | |
Angela C Onwuanibe, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 555 N Duke St, Lancaster, PA 17602 Phone: 717-544-5831 Fax: 717-544-5987 | |
Dr. Danielle Brewington Cross, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 555 North Duke Street, Lancaster, PA 17602 Phone: 717-544-5008 Fax: 717-544-5041 | |
Leopoldo Vocalan Jr., M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 802 New Holland Ave, Suite 100, Lancaster, PA 17602 Phone: 717-875-9267 |